Noble Financial
http://www.nobleresearch.com/index.htmNoble Financial is a capital markets firm. The firm provides private client services, equity research, sales and trading services, and investment banking services. The sectors in Noble’s coverage universe include healthcare services, media/entertainment, biotechnology, consumer, software, and business services.
View Older Stories View More Recent Stories
-
Noble Financial Boosts PT on 1-800-Flowers.com (FLWS) by ~14% Following Q4 Results, Outlook; Affirms at 'Buy'
-
Noble Financial Starts tronc, Inc. (TRNC) at Buy
-
Streetinsider.com's Hot Lunchtime Reads 8/17: (CXO) (CTAS) (HTBX) (MON)
-
Noble Financial Sees Multiple Readouts for Heat Biologics (HTBX) by YE16; Maintains 'Buy' Rating
-
Noble Financial Keeps Evoke Pharma (EVOK) at 'Hold' Following Q2 Numbers; Still Awaiting Development Plans
-
Noble Financial Downgrades The KEYW Holding Corporation (KEYW) to Hold
-
Noble Financial Keeps Agile Therapeutics (AGRX) at 'Buy'; Q2 Results Inline, Key Phase 3 Data Expected in Q4
-
Streetinsider.com's Hot Lunchtime Reads 8/3: (XON) (WMT) (QRVO) (MRCY)
-
Noble Financial Affirms Mercury Systems (MRCY) at 'Hold'; Solid End to FY, but Valuation Full
-
Noble Financial Positive on Adamas Pharma (ADMS) as Namzaric Gets Expanded Indication; Affirms at 'Buy'
-
Noble Financial Downgrades Evoke Pharma (EVOK) to Hold
-
Streetinsider.com's Hot Lunchtime Reads 7/15: (FUN) (TSLA) (IPG) (MSFT)
-
Noble Financial Positive on Peregrine Pharma (PPHN) Following Q4 Report; Says Contract Manufacturing to Drive Revs
-
Noble Financial Affirms TherapeuticsMD (TXMD) at 'Buy' Following Yuvvexy NDA Submission
-
Streetinsider.com's Hot Lunchtime Reads 7/7: (TSLA) (CMG) (MBI) (IONS)
-
Agile Therapeutics' (AGRX) Latest Hire Should Boost Key Ortho Evra Launch - Noble Financial
-
Streetinsider.com's Hot Lunchtime Reads 7/6: (NVDQ) (TSLA) (GCI) (RPAI)
-
Noble Financial Boosts PT on Avino Silver (ASM) to $3.25 Following Brexit Vote
-
Noble Financial Downgrades Galena Biopharma (GALE) to 'Hold'; PT Cut to $0.40
-
Noble Affirms Gannett (GCI) at 'Buy' Amid ReachLocal (RLOC) Deal; Takes Cautious Approach to Integration
-
Noble Financial Upgrades CACI International (CACI) to Buy
-
Noble Financial Thinks Cumulus Media's (CMLS) CFO Transition is 'Not A Good Sign'
-
Nobel Financial Affirms Adamas Pharma (ADMS) at 'Buy' Following Updated ADS-5102 Phase 3 Data in LID
-
Noble Financial Starts Adamas Pharmaceuticals (ADMS) at Buy
-
Notable 52-Week Highs and Lows 6/15: (ASM) (NVDA) High; (DRYS) (IMGN) Low
-
Avino (ASM) Ready to Begin Next Phase of Growth Cycle; Noble Financial Affirms at 'Buy'
-
Scripps' (SSP) Acquisition of Stitcher Should Pair Nicely with Midroll - Noble Financial
-
Streetinsider.com's Hot Lunchtime Reads 6/1: (GALE) (ABT) (CRM) (BIIB)
-
Noble Financial Positive on Galena Biopharma (GALE) Following NeuVax Fast Track Designation; Sees Development in Expeditious Manner
-
Noble Financial's 'Buy' Thesis on Nexstar Broadcasting (NXST) Reaffirmed; Shares Still Trading at Favorable Levels
-
Streetinsider.com's Hot Lunchtime Reads 5/19: (RGS) (GOGO) (XBIT) (HZNP)
-
Noble Financial Keeps XBiotech (XBIT) at 'Buy' Following Q1 Update; Says Robust Pipeline Progressing Well
-
Noble Affirms KEYW Holding (KEYW) at 'Buy'; FY17 Expected to Produce Strong Results
-
Noble Financial Keeps Galena (GALE) at 'Buy'; Interim NeuVax Phase 3 Data Now in Focus
-
Strong Production, Lower Costs Bode Well for Jones Energy (JONE) in Q1; Noble Affirms at 'Hold'
-
Noble Financial Affirms Gannett (GCI) at 'Buy'; Sees Multiple Synergies in Tribune (TPUB) Deal
-
Noble Financial Affirms Heron Therapeutics (HRTX) at 'Buy'; Says Delay in Sustol Approval was Unusual
-
Noble Financial Upgrades Ducommun Incorporated (DCO) to Buy
-
No Joke: Cracked Deal is Positive Acquisition for Scripps (SSP) - Noble Financial
-
Noble Financial Cuts SeaChange (SEAC) to Hold; Sidelined Until Revenue Improvement Appears
-
SeaChange Int'l (SEAC) Names New CEO
-
SeaChange International Appoints Software Veteran Ed Terino to Chief Executive Officer
-
Notable Analyst Rating Changes 4/7: (MTH) (GT) (CBRL) Upgraded; (VZ) (HOG) (FFIV) Downgraded
-
Noble Financial Starts Eyegate Pharma (EYEG) at Buy; Notes Novel Eye Delivery Tech, Broad Spectrum Appeal
-
Noble Financial Affirms ContraVir Pharma (CTRV) at 'Buy' as CMX-157 Outpaces Gilead's (GILD) Tenofovir AF in HBV
-
Heat Biologics Announces Closing of Public Offering
-
Noble Financial Affirms ContraVir Pharma (CTRV) at 'Buy' Following Initiation of CMX157 Phase 1 in HBV
-
Heat Biologics (HTBX) Prices 9.1M Common Stock, Warrants Offering at $0.75/Unit
-
Heat Biologics Announces Public Offering of Common Stock and Warrants
-
Avino closes U.S. brokered public offering

